Rare Voices, Real Impact as Alexion Humanises Rare Disease Care

In this BioPharma Boardroom discussion, we speak with Christophe Hotermans, Head of Global Medical Affairs at Alexion, AstraZeneca Rare Disease. From the e...

July 21, 2025 | Monday | Interaction
10x Genomics and A*STAR GIS Launch Landmark Spatial Biology Study in Asia to Drive Cancer and Inflammation Breakthroughs

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases 10x Gen...

July 18, 2025 | Friday | News
Cytiva’s “In-Region, For-Region” Strategy Powers $1.6 Billion Global Biomanufacturing Expansion

Since 2019, Cytiva has committed over $1.6 billion to expand its global manufacturing capacity. In this exclusive conversation with BioPharma BoardRoom, Pi...

July 01, 2025 | Tuesday | Interview
Integrated CMC workflows for current and next-generation ADCs

ADCs are no longer a niche modality. To date, there are over a dozen approved ADCs on the market, and more than 500 programs are in clinical development, d...

June 16, 2025 | Monday | Expert Opinion
Taiwan Showcases Precision Medicine and Biomanufacturing Strength at BIO 2025 with 35 Firms and Global Start-Up Finalists

Taiwan's delegation, led by BPIPO (Biotechnology and Pharmaceutical Industries Promotion Office), organized by the Ministry of Economic Affairs, and...

June 13, 2025 | Friday | News
Sinovac’s Showdown: Board Fights Back Against Dissident Slate as $55/Share Dividend Hangs in Balance

Sinovac Biotech Ltd. (NASDAQ: SVA), a prominent player in China's biopharmaceutical sector, has entered a defining phase in its corporate history. As the...

June 13, 2025 | Friday | Reports
Forging the Future of Biomanufacturing: How VVMF and Cytiva Are Elevating Australia’s Global Role

As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—espec...

June 05, 2025 | Thursday | Interaction
Trethera Secures Exclusive Worldwide License From UCLA to Expand TRE-515 Patent Protection

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

June 04, 2025 | Wednesday | News
Why CPOs are vital to getting medical trials over the line

While studies to test the safety and efficacy of new drugs are necessary, their success cannot be guaranteed. In fact, it’s likely that at least 80...

May 28, 2025 | Wednesday | News
Croda Strengthens Executive Team with Appointment of Stephen Oxley as CFO and Dr. Thomas Riermeier as President of Life Sciences

Croda is pleased to announce the appointments of Stephen Oxley as Chief Financial Officer (CFO) and Executive Director, and Dr. Thomas Riermeier as Presi...

April 01, 2025 | Tuesday | News
U.S. Bioscience Economy: A Catalyst for Innovation, Economic Growth, and Global Leadership

  The bioscience economy in the United States has evolved into a critical driver of innovation, economic growth, and soci...

December 03, 2024 | Tuesday | Reports
23andMe CEO Anne Wojcicki Announces Major Restructuring with 40% Workforce Reduction and Shift Away from Therapeutics

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commenc...

November 12, 2024 | Tuesday | News
BioPharma Boardroom Editorial Calendar 2025

Website: www.biopharmaboardroom.com Request Interactions & Submission : editor@biopharmboardroom.com   January 2025 Theme: Regulatory and AI...

October 05, 2024 | Saturday | Reports
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close